{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:08:21Z","timestamp":1788563301242,"version":"build-2803163510"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Respiratory viral infection (RVI) is a significant complication in patients with hematologic malignancies. While risk factors of lower respiratory tract infections (LRIs) and mortality have been studied in allogeneic hematopoietic cell transplant recipients, data remain limited for patients with lymphoma and multiple myeloma (MM). We investigated outcomes and risk factors of LRI and mortality secondary to respiratory syncytial virus (RSV) or influenza virus (IFV) infections in these populations.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We performed a retrospective study in adults with lymphoma or MM with RSV or IFV RVIs between 2016 and 2022. Primary outcomes were LRI and all-cause 30- and 90-day mortality.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We analyzed 440 patients with 490 consecutive viral episodes: 297 (61%) with MM and 193 (39%) with lymphoma, 258 (52%) were IFV-related, and 234 (48%) RSV-related (2 coinfections). At presentation, 62% were diagnosed with upper respiratory tract infection (URI) and 38% with LRI. During follow-up, 57% were hospitalized, 8% required intensive care unit transfer, and 20 (4%) died within 30 days. On multivariable analysis, RSV infection (vs IFV), current\/former smoking, steroid exposure, lymphopenia (\u2264200 cells\/mL), and high serum creatinine were associated with LRI. MM (vs lymphoma) diagnosis, current\/former smoking, lymphopenia, and nosocomial infection were associated with 30-day mortality, whereas LRI (vs URI), current\/former smoking, and lymphopenia were associated with 90-day mortality.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>We described a high burden of IFV and RSV infections in patients with lymphoma and MM and found risk factors associated with LRI and mortality. These factors could potentially identify high-risk patients, enabling better and prompt management strategies.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ofid\/ofaf127","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T02:08:05Z","timestamp":1741140485000},"source":"Crossref","is-referenced-by-count":6,"title":["Outcomes and Risk Factors for Influenza and Respiratory Syncytial Virus Lower Respiratory Tract Infections and Mortality in Patients With Lymphoma or Multiple Myeloma: A 7-Year Retrospective Cohort Study"],"prefix":"10.1093","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6675-7362","authenticated-orcid":false,"given":"Tali","family":"Shafat","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center , Houston, Texas ,","place":["USA"]},{"name":"European Society of Clinical Microbiology and Infectious Diseases Study Group for Respiratory Viruses , Basel ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6351-0302","authenticated-orcid":false,"given":"Daniel","family":"De-la-Rosa-Martinez","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Instituto Nacional de Cancerolog\u00eda , M\u00e9xico City ,","place":["M\u00e9xico"]},{"name":"Programa de Estudios Combinados en Medicina, Facultad de Medicina, Universidad Nacional Aut\u00f3noma de M\u00e9xico , M\u00e9xico City ,","place":["M\u00e9xico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4424-283X","authenticated-orcid":false,"given":"Fareed","family":"Khawaja","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center , Houston, Texas ,","place":["USA"]},{"name":"European Society of Clinical Microbiology and Infectious Diseases Study Group for Respiratory Viruses , Basel ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center , Houston, Texas ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Spallone","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center , Houston, Texas ,","place":["USA"]},{"name":"European Society of Clinical Microbiology and Infectious Diseases Study Group for Respiratory Viruses , Basel ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjorie Vieira","family":"Batista","sequence":"additional","affiliation":[{"name":"European Society of Clinical Microbiology and Infectious Diseases Study Group for Respiratory Viruses , Basel ,","place":["Switzerland"]},{"name":"Department of Infectious Diseases, AC Camargo Cancer Center , S\u00e3o Paulo ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella","family":"Ariza-Heredia","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center , Houston, Texas ,","place":["USA"]},{"name":"European Society of Clinical Microbiology and Infectious Diseases Study Group for Respiratory Viruses , Basel ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Vilar-Compte","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Instituto Nacional de Cancerolog\u00eda , M\u00e9xico City ,","place":["M\u00e9xico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7302-8299","authenticated-orcid":false,"given":"Sairah","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Departments of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center , Houston, Texas ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melody","family":"Becnel","sequence":"additional","affiliation":[{"name":"Departments of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center , Houston, Texas ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0277-3088","authenticated-orcid":false,"given":"Roy F","family":"Chemaly","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center , Houston, Texas ,","place":["USA"]},{"name":"European Society of Clinical Microbiology and Infectious Diseases Study Group for Respiratory Viruses , Basel ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,3,4]]},"reference":[{"key":"2025052712074628500_ofaf127-B1","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/01.md.0000232560.22098.4e","article-title":"Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center","volume":"85","author":"Chemaly","year":"2006","journal-title":"Medicine (Baltimore)"},{"key":"2025052712074628500_ofaf127-B2","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.idc.2019.02.004","article-title":"Respiratory virus infections of the stem cell transplant recipient and the hematologic malignancy patient","volume":"33","author":"Fontana","year":"2019","journal-title":"Infect Dis Clin North Am"},{"issue":"Suppl 5","key":"2025052712074628500_ofaf127-B3","doi-asserted-by":"crossref","first-page":"S344","DOI":"10.1093\/cid\/ciu623","article-title":"Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies","volume":"59","author":"Chemaly","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2025052712074628500_ofaf127-B4","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.cmi.2023.04.021","article-title":"Ribavirin treatment for respiratory syncytial virus infection in patients with haematologic malignancy and haematopoietic stem cell transplant recipients: a systematic review and meta-analysis","volume":"29","author":"Manothummetha","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"2025052712074628500_ofaf127-B5","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1016\/j.clinthera.2021.03.002","article-title":"Impact of influenza infection among adult and pediatric populations with hematologic malignancy and hematopoietic stem cell transplant: a systematic review and meta-analysis","volume":"43","author":"Atalla","year":"2021","journal-title":"Clin Ther"},{"key":"2025052712074628500_ofaf127-B6","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1182\/blood-2013-12-541359","article-title":"Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infections","volume":"123","author":"Shah","year":"2014","journal-title":"Blood"},{"key":"2025052712074628500_ofaf127-B7","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/jmv.24930","article-title":"Influenza in patients with hematological malignancies: experience at two comprehensive cancer centers","volume":"90","author":"Vilar-Compte","year":"2018","journal-title":"J Med Virol"},{"key":"2025052712074628500_ofaf127-B8","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1007\/s00520-018-4079-3","article-title":"Community-acquired respiratory infections are common in patients with non-Hodgkin lymphoma and multiple myeloma","volume":"26","author":"Lavi","year":"2018","journal-title":"Support Care Cancer"},{"key":"2025052712074628500_ofaf127-B9","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1093\/jac\/dky311","article-title":"Leukopenia and lack of ribavirin predict poor outcomes in patients with haematological malignancies and respiratory syncytial virus infection","volume":"73","author":"Azzi","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2025052712074628500_ofaf127-B10","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1007\/s00520-014-2550-3","article-title":"Risks and burden of viral respiratory tract infections in patients with multiple myeloma in the era of immunomodulatory drugs and bortezomib: experience at an Australian cancer hospital","volume":"23","author":"Teh","year":"2015","journal-title":"Support Care Cancer"},{"key":"2025052712074628500_ofaf127-B11","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.jtct.2023.09.018","article-title":"American Society of Transplantation and Cellular Therapy Series: #7\u2014management of respiratory syncytial virus infections in hematopoietic cell transplant recipients","volume":"29","author":"El Chaer","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"Suppl 2","key":"2025052712074628500_ofaf127-B12","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2025052712074628500_ofaf127-B13","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s13045-021-01177-0","article-title":"COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)","volume":"14","author":"Pagano","year":"2021","journal-title":"J Hematol Oncol"},{"key":"2025052712074628500_ofaf127-B14","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1182\/bloodadvances.2021005691","article-title":"A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study","volume":"6","author":"Visco","year":"2022","journal-title":"Blood Adv"},{"key":"2025052712074628500_ofaf127-B15","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1365-2141.2007.06705.x","article-title":"Immunodeficiency and immunotherapy in multiple myeloma","volume":"138","author":"Pratt","year":"2007","journal-title":"Br J Haematol"},{"key":"2025052712074628500_ofaf127-B16","doi-asserted-by":"crossref","first-page":"e12994","DOI":"10.1111\/tid.12994","article-title":"Risk factors for mortality after respiratory syncytial virus lower respiratory tract infection in adults with hematologic malignancies","volume":"20","author":"Vakil","year":"2018","journal-title":"Transpl Infect Dis"},{"key":"2025052712074628500_ofaf127-B17","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2141.2008.07295.x","article-title":"The challenge of respiratory virus infections in hematopoietic cell transplant recipients","volume":"143","author":"Boeckh","year":"2008","journal-title":"Br J Haematol"},{"key":"2025052712074628500_ofaf127-B18","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.3324\/haematol.2018.215152","article-title":"Respiratory syncytial virus in hematopoietic cell transplant recipients and patients with hematologic malignancies","volume":"104","author":"Khawaja","year":"2019","journal-title":"Haematologica"},{"key":"2025052712074628500_ofaf127-B19","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1182\/blood-2009-11-255455","article-title":"How I treat influenza in patients with hematologic malignancies","volume":"115","author":"Casper","year":"2010","journal-title":"Blood"},{"key":"2025052712074628500_ofaf127-B20","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.bbmt.2015.11.015","article-title":"Outcomes of influenza infections in hematopoietic cell transplant recipients: application of an immunodeficiency scoring Index","volume":"22","author":"Kmeid","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"2025052712074628500_ofaf127-B21","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1200\/JCO.24.00032","article-title":"Vaccination of adults with cancer: ASCO guideline","volume":"42","author":"Kamboj","year":"2024","journal-title":"J Clin Oncol"},{"key":"2025052712074628500_ofaf127-B22","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1002\/cncr.28351","article-title":"Clinical effectiveness of seasonal influenza vaccine among adult cancer patients","volume":"119","author":"Vinograd","year":"2013","journal-title":"Cancer"},{"key":"2025052712074628500_ofaf127-B23","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1093\/cid\/ciy294","article-title":"A 5-year prospective multicenter evaluation of influenza infection in transplant recipients","volume":"67","author":"Kumar","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2025052712074628500_ofaf127-B24","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s10875-007-9073-3","article-title":"Immunogenicity of influenza vaccination in patients with non-Hodgkin lymphoma","volume":"27","author":"Centkowski","year":"2007","journal-title":"J Clin Immunol"},{"key":"2025052712074628500_ofaf127-B25","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1056\/NEJMoa2209604","article-title":"Respiratory syncytial virus prefusion F protein vaccine in older adults","volume":"388","author":"Papi","year":"2023","journal-title":"N Engl J Med"},{"key":"2025052712074628500_ofaf127-B26","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1056\/NEJMoa2213836","article-title":"Efficacy and safety of a bivalent RSV prefusion F vaccine in older adults","volume":"388","author":"Walsh","year":"2023","journal-title":"N Engl J Med"},{"key":"2025052712074628500_ofaf127-B27","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1182\/blood-2010-08-263400","article-title":"Management of RSV infections in adult recipients of hematopoietic stem cell transplantation","volume":"117","author":"Shah","year":"2011","journal-title":"Blood"},{"key":"2025052712074628500_ofaf127-B28","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1007\/s12325-022-02256-5","article-title":"Ribavirin for treatment of subjects with respiratory syncytial virus\u2013related infection: a systematic review and meta-analysis","volume":"39","author":"Tejada","year":"2022","journal-title":"Adv Ther"},{"key":"2025052712074628500_ofaf127-B29","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1186\/s12889-023-17406-9","article-title":"Spatiotemporal variations of \u201ctriple-demic\u201d outbreaks of respiratory infections in the United States in the post-COVID-19 era","volume":"23","author":"Luo","year":"2023","journal-title":"BMC Public Health"},{"key":"2025052712074628500_ofaf127-B30","doi-asserted-by":"crossref","first-page":"355","DOI":"10.15585\/mmwr.mm7214a1","article-title":"Seasonality of respiratory syncytial virus\u2014United States, 2017\u20132023","volume":"72","author":"Hamid","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025052712074628500_ofaf127-B31","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.ijid.2022.08.002","article-title":"Understanding the rebound of influenza in the post COVID-19 pandemic period holds important clues for epidemiology and control","volume":"122","author":"Lee","year":"2022","journal-title":"Int J Infect Dis"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofaf127\/62266463\/ofaf127.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/12\/4\/ofaf127\/62266463\/ofaf127.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/12\/4\/ofaf127\/62266463\/ofaf127.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T16:08:12Z","timestamp":1748362092000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofaf127\/8051878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,4]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,3,27]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofaf127","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2025,3,4]]},"article-number":"ofaf127"}}